These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21350286)

  • 21. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S
    BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of photodynamic therapy with intravitreal bevacizumab for post-peribulbar anesthesia (penetrating trauma)-persistent choroidal neovascular membrane.
    Shah N; Shah U
    Indian J Ophthalmol; 2008; 56(2):163-4. PubMed ID: 18292635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy.
    Montero JA; Ruiz-Moreno JM; Fernandez-Muñoz M
    Eur J Ophthalmol; 2011; 21(4):503-5. PubMed ID: 21279982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses.
    Ruiz-Moreno JM; Montero JA; Amat-Peral P
    Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):595-9. PubMed ID: 21234588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hayashi W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.
    Tran TH; Fardeau C; Terrada C; Ducos De Lahitte G; Bodaghi B; Lehoang P
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1685-92. PubMed ID: 18682970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy.
    Mandal S; Sinha S; Abbas Z; Venkatesh P
    Indian J Ophthalmol; 2011; 59(4):338-9. PubMed ID: 21666337
    [No Abstract]   [Full Text] [Related]  

  • 30. Antivascular Endothelial Growth Factor Monotherapy for Choroidal Neovascularization Associated With Retinochoroidal Coloboma: Case Series.
    Bondalapati S; Jalali S; Chhablani J
    Asia Pac J Ophthalmol (Phila); 2016; 5(5):344-8. PubMed ID: 26918902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
    Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
    Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.
    Shah NJ; Shah UN
    Indian J Ophthalmol; 2011; 59(4):318-9. PubMed ID: 21666322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.
    Bashshur ZF; Schakal A; Hamam RN; El Haibi CP; Jaafar RF; Noureddin BN
    Arch Ophthalmol; 2007 Oct; 125(10):1357-61. PubMed ID: 17923543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
    Teixeira A; Mattos T; Velletri R; Teixeira R; Freire J; Moares N; Bonomo PP
    Ophthalmic Surg Lasers Imaging; 2010; 41(5):546-9. PubMed ID: 20795575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for occult and classic CNV in AMD].
    Maier M; Haas K; Feucht N; Fiore B; Winkler von Mohrenfels C; Clos A; Lohmann C
    Klin Monbl Augenheilkd; 2008 Jul; 225(7):653-9. PubMed ID: 18642209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination treatment of low fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane secondary to angioid streaks in Paget's disease - 12 month results.
    Prabhu VV; Morris RJ; Shah PK; Narendran V
    Indian J Ophthalmol; 2011; 59(4):306-8. PubMed ID: 21666317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series.
    Donati MC; Virgili G; Bini A; Giansanti F; Rapizzi E; Giacomelli G; Menchini U
    Ophthalmologica; 2009; 223(1):24-7. PubMed ID: 18849633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen.
    Knape RM; Zavaleta EM; Clark CL; Khuddus N; Peden MC
    J AAPOS; 2011 Feb; 15(1):87-90. PubMed ID: 21397813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple therapy for neovascular age-related macular degeneration (verteporfin photodynamic therapy, intravitreal dexamethasone, and intravitreal bevacizumab).
    Ehmann D; García R
    Can J Ophthalmol; 2010 Feb; 45(1):36-40. PubMed ID: 20130708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.